Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AME of KD101 in Male Subjects
NCT02819934Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of KD101 in obesity, sponsored by Seoul National University Hospital. Primary endpoint: Total radioactivity at feces, urine, blood to measure total recovery rate at 13 days. Started May 2016; status: completed.
02
Drugs
KD101
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02819934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819934.